Identification of CD146 as a novel molecular actor involved in systemic sclerosis
Élise Kaspi(Inserm), Nathalie Bardin(Inserm)
Cited by 23
Related Papers
Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351
|Journal of Controlled Release|2021|9
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic Sclerosis
|Journal of Investigative Dermatology|2022|8